Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2003
06/19/2003US20030113803 Orphan receptor
06/19/2003US20030113798 Antigenic peptides, such as for G protein-coupled receptors (GPCRS), antibodies thereto, and systems for identifying such antigenic peptides
06/19/2003US20030113792 Epoxide polymer surfaces
06/19/2003US20030113791 CIF130 inhibits cell cycle progression
06/19/2003US20030113790 26343, a novel human oxidoreductase and uses therefor
06/19/2003US20030113789 Protease peptides; anticarcinogenic agents; neurotransmitters; antidiabetic agents
06/19/2003US20030113785 Methods for the identification of herbicides and the modulation of plant growth
06/19/2003US20030113784 Regulated expression of recombinant DNA
06/19/2003US20030113781 Hybridization probes; oligonucleotide primers; polymerase chain reaction; disease and infection diagnosis
06/19/2003US20030113780 Antibodies to crosslinkers and methods for using the same
06/19/2003US20030113779 High-throughput assay for detection of conformational changes in RNA sequences; rev genes/proteins; fluorescent in situ hybridization
06/19/2003US20030113775 7118, a human arginine N-methyltransferase family member and uses therefor
06/19/2003US20030113772 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113771 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113764 Compositions and methods for the treatment of tumors
06/19/2003US20030113763 Oligonucleotide compositions and their use to induce apoptosis
06/19/2003US20030113760 Transforming cancerous tissue making it sensitive to antiproliferative agents and viricidal agents; suicide gene therapy; cancer diagnosis
06/19/2003US20030113759 Method of DNA shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process
06/19/2003US20030113757 Use of oligonucleotide primers and polymerase chain reaction in screening for gramnegative bacteria in food and water; gastrointestinal disorders; food poisoning
06/19/2003US20030113755 Fluorescent nucleotides and labeling methods using the same
06/19/2003US20030113754 In vitro replication of RNA sequences; gene expression analysis; reverse transcription
06/19/2003US20030113752 Detecting demyelinating nervous system disorder by measurement of stem cell factor (SCF)-apoptosis-response gene protein(SARG-1-) protein; antiproliferative agents; microtubule associated protein 1(map1a); cancer screening
06/19/2003US20030113750 Diagnosing cancer of urogenital systems using oligonucleotides/peptide nucleic acids or cytosine methylation; matrix assisted laser desorption ionization/electron spray mass spectrometry
06/19/2003US20030113749 Interaction trap systems for detecting protein interactions
06/19/2003US20030113747 Genetically engineered adenosine triphosphate generating polypeptide; sequences determination; reporter molecules
06/19/2003US20030113743 Method for detection of micrometastatic prostate cancer
06/19/2003US20030113742 Methods and compositions for the modulation of biofilm formation
06/19/2003US20030113739 Robotic preparation of antisense agents; antitumor agents; antiapoptosis agents; antiinflammatory agents
06/19/2003US20030113738 Replication; hybridization; drug screening
06/19/2003US20030113735 Glucanases/glucosidase/hydrolases; conversion of cellulose to sugars and/or ethanol; laundering detergents
06/19/2003US20030113734 EGVII endoglucanase and nucleic acids encoding the same
06/19/2003US20030113732 EGVI endoglucanase and nucleic acids encoding the same
06/19/2003US20030113723 High throughput screening for colorectal cancer
06/19/2003US20030113717 Directed evolution of novel binding proteins
06/19/2003US20030113716 Nucleic acid multiplex formation
06/19/2003US20030113715 Oligonucleotide sequence probes; for detection of non-ribosome lyases; veterinary medicine; agriculture
06/19/2003US20030113714 Binding peptides to polycrystalline semiconductors; detection of bacteriophages; high density magnetic storage; medical imaging; forensics; antitumor agents; anticarcinogenic agents
06/19/2003US20030113713 Methods and apparatus for conducting multiple measurements on a sample
06/19/2003US20030113712 Compositions and methods for reverse transcriptase-polymerase chain reaction (RT-PCR)
06/19/2003US20030113710 Immobilization; antibiotic resistance; drug screening
06/19/2003US20030113705 Inhibiting proteolytic enzymes in urine/blood samples by binding trace elements, reducing degradation of cell walls
06/19/2003US20030113368 Holding capability for hydrophilic and lipophilic drugs, water-soluble and hydrophobic substaces; controlling sustained release
06/19/2003US20030113348 Non-laboratory strain used in the manufacture of a medicament for the oncolytic treatment of cancer; anticancer agents
06/19/2003US20030113339 Methods to improve immunogenicity of antigens and specificity of antibodies
06/19/2003US20030113338 Immunogenic detoxified mutant e. coli lt-a toxin
06/19/2003US20030113337 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
06/19/2003US20030113333 A kit containing a binding protein and a carrier molecule, binds with a hapten moiety and binds with a target antigen; monoclonal antibodies and engineered antibodies
06/19/2003US20030113321 Novel G-protein-coupled receptor protein and its DNA
06/19/2003US20030113296 A tissue-specific transcriptional regulatory sequence(promoter or enhancer) operably linked to the coding region of a gene that is essential of replication of the vector (DNA tumor viral vector)
06/19/2003US20030113295 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders
06/19/2003US20030111348 Electrophoresis chip
06/19/2003CA2848193A1 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
06/19/2003CA2784260A1 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003CA2783164A1 Stabilisation of double-stranded nucleic acids using proteins
06/19/2003CA2718374A1 Extraction and winterization of lipids from oilseed and microbial sources
06/19/2003CA2692325A1 Islet cells from human embryonic stem cells
06/19/2003CA2474152A1 Methods and materials for the production of organic products in cells of candida species
06/19/2003CA2472054A1 Compositions and methods for normalizing assays
06/19/2003CA2469923A1 Biallelic markers of d-amino acid oxidase and uses thereof
06/19/2003CA2469802A1 A structure for presenting desired peptide sequences
06/19/2003CA2469695A1 Methods for the identification of inhibitors of asparagine synthase, 5-aminolevulinate synthase, histidinol-phosphatase, 3-isopropylmalate and threonine synthase as antibiotics
06/19/2003CA2469679A1 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003CA2469620A1 Immunisation against chlamydia trachomatis
06/19/2003CA2469607A1 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003CA2469561A1 Methods for determining transcriptional activity
06/19/2003CA2469494A1 Novel chimeric tnf ligands
06/19/2003CA2469491A1 Composition for viral preservation
06/19/2003CA2469383A1 Hybridization portion control oligonucleotide and its uses
06/19/2003CA2469301A1 Functionalized materials and libraries thereof
06/19/2003CA2469257A1 Method of preparing eggs for nuclear transfer and uses thereof
06/19/2003CA2469161A1 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003CA2469049A1 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003CA2469027A1 Human genes and gene expression products isolated from human prostate
06/19/2003CA2468842A1 High resolution typing system for pathogenic e. coli
06/19/2003CA2468753A1 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
06/19/2003CA2468750A1 Automatic electroporation optimization system
06/19/2003CA2468579A1 Nucleic acids related to plant retroelements
06/19/2003CA2468335A1 Chondrocyte precursors derived from human embryonic stem cells
06/19/2003CA2468297A1 Method of purifying hepatitis a virus particles and vaccine preparation
06/19/2003CA2467736A1 Flexible method and apparatus for high throughput production and purification of multiple proteins
06/19/2003CA2467689A1 Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
06/19/2003CA2467505A1 Expression system
06/19/2003CA2461491A1 Methods of screening for antagonists of apm1/gzip
06/19/2003CA2413669A1 Reagent for improved pcr
06/19/2003CA2411031A1 Nucleic acid, probe comprising the nucleic acid and screening method using the probe
06/18/2003EP1319952A2 Transgenic fatty acid transport (FATP) non-human knockout mammals and uses thereof
06/18/2003EP1319950A1 Matrix screening method
06/18/2003EP1319721A1 Method for determining chum salmon haplotype using mitochondrial DNA
06/18/2003EP1319719A1 Reversibly modified thermostable enzymes for DNA synthesis and amplification in vitro
06/18/2003EP1319718A1 High throughput analysis and detection of multiple target sequences
06/18/2003EP1319717A1 Method for detection of inflammatory processes
06/18/2003EP1319716A1 Method of analyzing nucleic acid
06/18/2003EP1319715A1 IMP dehydrogenase and its use for the identification of fungicidal substances
06/18/2003EP1319713A1 Complex
06/18/2003EP1319712A2 Fusion protein having enhanced in vivo activity of erythropoietin
06/18/2003EP1319711A2 Production of pharmaceutical-grade plasmid DNA
06/18/2003EP1319710A1 Method of forming complex
06/18/2003EP1319709A1 Disruption of the glutathione S-transferase-omega-1 gene
06/18/2003EP1319669A2 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
06/18/2003EP1319419A1 Method of administration of a gene of interest to a vascular tissue
1 ... 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 ... 4023